Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/105820
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Coimbra, Judite R. M. | - |
dc.contributor.author | Baptista, Salete | - |
dc.contributor.author | Dinis, Teresa | - |
dc.contributor.author | Silva, Maria M. C. | - |
dc.contributor.author | Moreira, Paula I. | - |
dc.contributor.author | Santos, Armanda Emanuela Castro e | - |
dc.contributor.author | Salvador, Jorge A. R. | - |
dc.date.accessioned | 2023-03-09T11:40:23Z | - |
dc.date.available | 2023-03-09T11:40:23Z | - |
dc.date.issued | 2020-04-01 | - |
dc.identifier.issn | 2218-273X | pt |
dc.identifier.uri | https://hdl.handle.net/10316/105820 | - |
dc.description.abstract | The treatment options for a patient diagnosed with Alzheimer's disease (AD) are currently limited. The cerebral accumulation of amyloid-β (Aβ) is a critical molecular event in the pathogenesis of AD. When the amyloidogenic β-secretase (BACE1) is inhibited, the production of Aβ peptide is reduced. Henceforth, the main goal of this study is the discovery of new small bioactive molecules that potentially reach the brain and inhibit BACE1. The work was conducted by a customized molecular modelling protocol, including pharmacophore-based and molecular docking-based virtual screening (VS). Structure-based (SB) and ligand-based (LB) pharmacophore models were designed to accurately screen several drug-like compound databases. The retrieved hits were subjected to molecular docking and in silico filtered to predict their ability to cross the blood-brain barrier (BBB). Additionally, 34 high-scoring compounds structurally distinct from known BACE1 inhibitors were selected for in vitro screening assay, which resulted in 13 novel hit-compounds for this relevant therapeutic target. This study disclosed new BACE1 inhibitors, proving the utility of combining computational and in vitro approaches for effectively predicting anti-BACE1 agents in the early drug discovery process. | pt |
dc.language.iso | eng | pt |
dc.publisher | MDPI | pt |
dc.relation | CENTRO-01-0247-FEDER-003269 (Drugs2CAD) | pt |
dc.relation | CENTRO-01-0145-FEDER-000012 (HealthyAging2020) | pt |
dc.relation | UIDB/04539/2020 | pt |
dc.relation | RECI/QEQ-QFI/0168/2012 | pt |
dc.relation | CENTRO-07-CT62-FEDER-002012 | pt |
dc.relation | UID/QUI/00313/2019 | pt |
dc.relation | SFRH/BD/138460/2018 | pt |
dc.relation | University of Coimbra | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject | Alzheimer’s disease (AD) | pt |
dc.subject | amyloid- (A ) | pt |
dc.subject | BACE1 | pt |
dc.subject | small bioactive molecules | pt |
dc.subject | virtual screening | pt |
dc.subject | pharmacophore modelling | pt |
dc.subject | molecular docking | pt |
dc.subject | structure- and ligand-based methods | pt |
dc.subject.mesh | Amyloid Precursor Protein Secretases | pt |
dc.subject.mesh | Blood-Brain Barrier | pt |
dc.subject.mesh | Drug Evaluation, Preclinical | pt |
dc.subject.mesh | Ligands | pt |
dc.subject.mesh | Molecular Docking Simulation | pt |
dc.subject.mesh | Protease Inhibitors | pt |
dc.subject.mesh | Protein Conformation | pt |
dc.subject.mesh | User-Computer Interface | pt |
dc.title | Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors | pt |
dc.type | article | - |
degois.publication.firstPage | 535 | pt |
degois.publication.issue | 4 | pt |
degois.publication.title | Biomolecules | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.3390/biom10040535 | pt |
degois.publication.volume | 10 | pt |
dc.date.embargo | 2020-04-01 | * |
uc.date.periodoEmbargo | 0 | pt |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | open | - |
item.openairetype | article | - |
item.languageiso639-1 | en | - |
item.fulltext | Com Texto completo | - |
item.cerifentitytype | Publications | - |
crisitem.project.grantno | Center for Innovative Biomedicine and Biotechnology - CIBB | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.researchunit | CQC - Coimbra Chemistry Centre | - |
crisitem.author.parentresearchunit | Faculty of Sciences and Technology | - |
crisitem.author.orcid | 0000-0001-5913-3834 | - |
crisitem.author.orcid | 0000-0001-6350-5741 | - |
crisitem.author.orcid | 0000-0002-1938-4150 | - |
crisitem.author.orcid | 0000-0001-5177-6747 | - |
crisitem.author.orcid | 0000-0003-1111-2481 | - |
crisitem.author.orcid | 0000-0003-0779-6083 | - |
Appears in Collections: | FFUC- Artigos em Revistas Internacionais I&D CIBB - Artigos em Revistas Internacionais I&D ICBR - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
biomolecules-10-00535-v2.pdf | 7.48 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
16
checked on Aug 26, 2024
WEB OF SCIENCETM
Citations
13
checked on Aug 2, 2024
Page view(s)
107
checked on Aug 27, 2024
Download(s)
38
checked on Aug 27, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License